Global Generic Drug Market 2025 – 2034

Reports Description

According to Custom Market Insights (CMI), The Global Generic Drug Market Size was valued at USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025, is estimated to reach USD 926.54 Billion by the end of 2034 at a CAGR of approximately 6.55% during the forecast period 2025-2034.

To learn more about this report - request a sample report PDF

The market has recently seen a rise in demand for generic medications as a result of individuals becoming more aware of the range of affordable options offered by both the public and private sectors. Also, the main market players' considerable research and development efforts to bring cutting-edge medications under the umbrella of generic drugs have helped the market to experience phenomenal growth over the course of the projection period.

The vast aging population has contributed to a sharp rise in patient numbers globally, which has helped the market reach new heights. People frequently choose generic medications since they work similarly to branded medications in terms of how they affect the body. Also, the prevalence of chronic diseases among individuals around the world has contributed to the generic medication market's notable growth. The market always necessitates the demand and supply of specific medicines since chronic illnesses take a long time to fully treat. As a result, the ability of these medications, which fall into the generic drug category, has been developing, greatly accelerating the market's growth.

To learn more about this report - request a sample report PDF

COVID-19 Analysis:

• Due to the enormous demand and supply that existed in the market, the COVID pandemic outbreak had a substantial impact on the generic medication industry.
• The people who were affected by the epidemic also endured a number of related illnesses and ailments, adding to the financial burden on the populace. As a result, the leading market participants' provision of cutting-edge generic medications became apparent as a feasible solution for these individuals.

People's growing preference for generic medications due to their similarity to the medicine's primary ingredients has enabled the market to expand significantly over the course of the forecast period. As a result, the market placed a huge demand on the sales and supply of medications that affect the cardiovascular system. Also, the large number of persons who had the disease during the pandemic contributed to the market for generic medications seeing enormous growth. In order to lower the overall cost of therapy, patients chose branded and pure generic medications.

Developing Factors:

• Leading players in the generic drug market have released new medications that use cutting-edge technology to treat patients and speed up cures while having fewer negative side effects on the body of the patient. T
• The economics of the market has been bolstered by significant investments made by the major market participants to improve and develop the production and manufacturing process for generic drugs.
• Modern technology has dramatically lowered the overall cost of production, which has become a key factor in the growth of the generic medication market.
• Also, the economy of the generic medicine industry has been greatly bolstered by recent developments that have occurred in the market in the form of acquisitions and collaborations among various market competitors.
• Additionally, growing consumer acceptance of generic medications has also been identified as a critical aspect that is anticipated to significantly increase market size during the projection period.
• The market's abundance of wholesale distributors and dealers has further boosted demand for generic medications.
• Also, the prevalence of various chronic conditions among older adults who already have a limited amount of disposable income emerges as a significant driving force that significantly boosts the market and is anticipated to continue to do so given the current market trend. During the anticipated period, these elements started to emerge as the market's drivers of growth.

Segmental Insights

Segmentation of the generic drug market based on Brand

Due to the high demand shown in the market, the segment of pure generics, based on the Brand, has proven to be the fastest-growing category. The segment of pure genetics has also shown great growth, and it is anticipated that this trend will continue in the future, thanks to the public's growing knowledge of the originality and quality of pharmaceuticals.

Pure generic drugs are now capturing the present industry thanks to the growing competition among the major market companies to introduce cutting-edge, extremely high-quality medications. The therapeutic value of pure generic medications is far higher than that of their rivals. The usage of pure generic medications has had a significant positive impact on people's health, which has increased life expectancy.

In order to meet their needs, potential customers also buy these medications in huge quantities. The necessity for specific components in medications has led to a sharp rise in the sales and demand of pure genetic drugs, which has significantly increased market size. On the other hand, because of their market recognition and brand value, branded generic medications are predicted to have a better future.

The branded generics' current position has been aided by the loyalty with which they have served the public. It enables people to select a better option than name-brand medications. Branded generics are slightly more expensive than their rivals, nevertheless. The supply and demand of branded generics have primarily increased in urban areas as a result of growing urbanization.

Segmentation of generic drugs based on the route of Administration

Oral formulations have dominated the market in terms of the Administration route. Almost all patients over the world have shown this administration method to be the most popular one. The oral route of administration has traditionally been regarded as the safest and most practical, for humans to animals. As a result, this mode of drug administration has seen the highest sales and demand in the pharmaceutical industry.

The market has seen a significant increase in demand for topical applications, which is anticipated to continue during the projected period. The need for topical applications has increased due to the rise in occurrences of skin problems. After oral preparations, it is regarded as the most practical mode of administration.

This method of administration is frequently used to treat skin conditions in infants and young children. Since the injection is regarded as a typical route of administration in the healthcare industry, it has also made a significant contribution to the market's expansion. Due to its quick effects on the physiological systems, this area is also seeing a growth in demand.

Segmentation of generic drugs based on Therapeutic Application

Due to the enormous number of patients present around the world, the oncology market sector has amassed the highest share in terms of therapeutic application. Cancer is a major cause of death in young and middle-aged persons. The market's high cost of treatment alternatives puts further strain on the average person's disposable money.

The availability of generic cancer medications on the market has greatly benefited society. Cardiovascular illnesses are the next sector that has had a significant growing contribution to the market. They must grow quickly during the projected time due to diseases of the cardiovascular system. Also, the younger generations are under immense pressure and stress owing to the workload, which has increased the number of people with cardiovascular illnesses.

Given the high cost of the medications used to treat cardiovascular disorders, generic medications are in high demand in the current market. The worldwide increase in pollution has also led to an increase in the number of occurrences of respiratory diseases. Moreover, the pandemic's effects on and deterioration of the respiratory system had a considerable negative impact on people's health. The number of occurrences of respiratory illnesses has also increased as a result of poor lifestyle choices.

Report Scope

Regional Perspectives:

Geographically speaking, North America is thought to be the largest consumer of generic medications. This is due to the fact that many residents of this area suffer from various chronic ailments. Also, as more residents of this region became aware of the healthcare services provided by public and private institutions, generic drug sales and demand grew quickly.

The huge increase in the population of elderly persons has increased the use of outdated medications. Also, the market for generic medications has grown due to the frequency of respiratory and cardiovascular disorders among people.

The high price of name-brand medications has increased the demand for generic medications as well. The Asia-Pacific region has become the generic medicine industry's second-largest market. The residents in this region are under added stress due to a lack of disposable income, which has significantly increased the demand for generic medications. Due to the enormous need for generic drugs, Europe and South America have made a substantial contribution to the market's expansion.

Key Players

• Alkem Laboratories Limited
• Teva Pharmaceutical Industries Limited
• Cipla Ltd.
• Reddy’s Laboratories Ltd.
• Mylan N.V.
• Lupin Limited
• STADA Arzneimittel AG
• Hikma Pharmaceuticals plc
• Torrent Pharmaceuticals Ltd.
• Endo International plc
• Aurobindo Pharma Limited
• Sawai Pharmaceutical Co. Ltd.
• Mallinckrodt plc
• Amneal Pharmaceuticals Inc.

Recent Development

• In September 2018 – Allergan purchased the California-based biotechnology company Bonti endurance biotech.
• In March 2019 - Allergan purchased Envy Medical, a biotechnology company that provides dermatology and medical aesthetic treatments.
• In 2018 – In order to expand its line of products for the elements that maintain the skin's elasticity, Allergan purchased Elastagen.

Segments covered in this report

By Brand

• Branded generic drugs
• Pure generic drugs

By Route of Administration

• Topical
• Oral
• Parental
• Others

By Therapeutic Application

• Cardiovascular system
• Oncology
• Dermatology
• Respiratory system
• Central nervous system
• Others

By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Others

On the basis of Geography

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America